Advertisement

Topics

Intervet/Schering-Plough Animal Health Company Profile

10:12 EST 13th December 2018 | BioPortfolio

Intervet/Schering-Plough Animal Health, based in Boxmeer, the Netherlands, is focused on the research, development, manufacturing and marketing of animal health products. The company offers customers one of the broadest, most innovative animal health portfolios, spanning products to support performance and to prevent, treat and control disease in all major farm and companion animal species. Intervet/Schering-Plough Animal Health; subsidiaries of Merck & Co. Inc., Whitehouse Station NJ, USA. For more information, visit www.intervet.com.


News Articles [837 Associated News Articles listed on BioPortfolio]

TerraGen, Schering-Plough Collaboration to Focus on Discovery of Anti-Infectives

TerraGen Discovery Inc. (Vancouver, BC, Canada) and Schering-Plough Research Institute (SPRI; Kenilworth, NJ) have established a second collaboration to discover novel anti-infective compounds...

Merck & Co.: Merging With Schering-Plough and Future Plans

In this episode of PharmaTelevision News Review, Fintan Walton talks with Pamela Demain, Executive Director, Corporate Licensing at Merck & Co. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, th...

Researchers Get Atomic View of FPT Inhibitors in Action

Researchers at Schering-Plough Research Institute report what they say is the first atomic view showing how FPT inhibitors work...

PTV News: Nov 5, 2009

Top stories on November 5th, 2009: Merck complete Schering-Plough merger Novartis buys Chinese vaccine maker BioPad’s Joe Mosala Molete on South African biotech Pfizer on partnering: Doug Giordan...

Bayer Schering Pharma: Michael Yeomans on Growth in Pharma and New Deals

In this episode of PharmaTelevision News Review, Fintan Walton talks with Michael Yeomans, VP Business Development & Licensing at Bayer Schering Pharma*. Filmed at BioChicago 2010 in Chicago, USA, the...

The New Merck

In recent years, Merck & Co.'s corporate strategy has included a significant amount of licensing and partnering in order to externalise their pipeline and ensure that the company gets access to the be...

Boehringer Ingelheim: Is Animal Health the sweet spot of the industry?

Dr Joachim Hasenmaier, corporate board divisions, Animal Health and Consumer Healthcare, discusses BI’s transformational swap with Sanofi, which has seen them acquire Sanofi’s Animal Health Divisi...

At the frontiers of animal health: a European perspective

In animal health, as in human health, scientific discoveries and technological innovations are constantly presenting new possibilities for the prevention and treatment of disease; however, these innov...

PubMed Articles [4319 Associated PubMed Articles listed on BioPortfolio]

Delivery and evaluation of participatory education for animal keepers led by veterinarians and para-veterinarians around the Kanha Tiger Reserve, Madhya Pradesh, India.

We aim to investigate local perceptions of animal health challenges; current animal health knowledge; and methods to provide effective, relevant education to animal keepers in the Kanha Tiger Reserve ...

A Determinants of Health Conceptual Model for Fish and Wildlife Health.

Our objectives were to establish if the determinant of health model used in the fields of human population and public health could be adapted to wildlife health; if it was applicable to more than one ...

Brucellosis is a public health problem in southern Italy: Burden and epidemiological trend of human and animal disease.

Brucellosis is the most common global bacterial zoonotic disease. Italian annual 2015 report on animal brucellosis control that was submitted to the Integrated National Plan of the Italian Health Mini...

Exploring the Social Determinants of Animal Health.

An understanding of the One Health and EcoHealth concepts by students is dependent on medical pedagogy and veterinary medical pedagogy having similarities that allow a common discourse. Medical pedago...

Climate change and One Health.

The journal The Lancet recently published a countdown on health and climate change. Attention was focused solely on humans. However, animals, including wildlife, livestock and pets, may also be impact...

Clinical Trials [3908 Associated Clinical Trials listed on BioPortfolio]

Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis

The primary objective of this study is to evaluate the clinical efficacy of the drug Cloratadd D ® (loratadine + pseudoephedrine sulfate - EMS S/A) compared to the drug Claritin D ® (lor...

Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets

The present study was a randomized, open-label, two-period, two-sequence, cross-over study, conducted to find out whether the etoricoxib 120 mg film-coated tablet produced by PT Dexa Medic...

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

To compare the single-dose oral bioavailability of loratadine 10 mg orally disintegrating tablets of Ohm Laboratories (a subsidiary of Ranbaxy Pharmaceuticals Inc., USA) with Claritin® Re...

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Aim: to observe the graft versus tumor effect of Pegylated Interferonα-2b in patients with hematological malignancies relapsed after allogeneic hematopoietic stem cell transplantation (al...

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects

To evaluate the bioequivalence of one extended release combination (loratadine 5 mg/pseudoephedrine sulfate 120 mg) tablet manufactured for Bayer HealthCare LLC by SAG Manufacturing, S.L.U...

Companies [2383 Associated Companies listed on BioPortfolio]

Intervet/Schering-Plough Animal Health

Intervet/Schering-Plough Animal Health, based in Boxmeer, the Netherlands, is focused on the research, development, manufacturing and marketing of animal health products. The company offers customers ...

Schering-Plough Corp.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies th...

Schering-Plough

Schering-Plough is committed to earning the trust of doctors, patients and customers every day. Our colleagues worldwide believe that trust is not easily granted, and that is the reason we focus each ...

Intervet International bv

Intervet Inc. is the U.S. operating division of Intervet International, the world's third leading animal health company.Our company is a leader in research and development of veterinary vaccines and p...

Schering-Plough Corporation

More Information about "Intervet/Schering-Plough Animal Health" on BioPortfolio

We have published hundreds of Intervet/Schering-Plough Animal Health news stories on BioPortfolio along with dozens of Intervet/Schering-Plough Animal Health Clinical Trials and PubMed Articles about Intervet/Schering-Plough Animal Health for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intervet/Schering-Plough Animal Health Companies in our database. You can also find out about relevant Intervet/Schering-Plough Animal Health Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record